Biomarkers in lung cancer.
Here we review the role of tissutal and circulating biomarkers in the management of lung cancer. In the past they were considerate quite ineffective tools as regards prognosis and prediction of treatment activity, nowadays instead, they are becoming a crucial key point as potential predictive issues in driving therapy, with possibly prognostic values as well.
Department of Medical Oncology, CRO-IRCCS, National Cancer Institute, Aviano, PN, Italy. abearz@cro.it
Alessandra
A
Bearz
Massimiliano
M
Berretta
Alessandro
A
Cappellani
Arben
A
Lleshi
Eleonora
E
Berto
Lucia
L
Fratino
Umberto
U
Tirelli
D014408:Biomarkers, Tumor / Q000097:blood*; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood*; D018288:Carcinoma, Small Cell / Q000097:blood*; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood*
D014408:Biomarkers, Tumor